Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × NSCLC × osimertinib × Clear all

Status

Sponsor Class

Study Type

Interventional 10 Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 12 Lung Neoplasms 3 T790M Positive NSCLC Patients 1 Sexual Dysfunction, Physiological 1 NSCLC 1 Eunuchism 1 Erectile Dysfunction 1 EGF-R Positive Non-Small Cell Lung Cancer 1

Interventions

pembrolizumab 1 osimertinib 1 icotinib 1 dacomitinib 1 camrelizumab 1 Radiofrequency Ablation 1 Gefitinib 1 Erlotinib Hydrochloride 1 Bevacizumab 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04575415 2020-10-20

BELLA

Guangdong Association of Clinical Trials

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡